Cross-Over Study of the Decongestant Effect of Phenylephrine Compared With Placebo and Pseudoephedrine as Active Control in SAR Subjects Exposed to Pollen in the Vienna Challenge Chamber

Registry ID

EUCTR2005-004309-27

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

Schering Plough Research Institute

Start date

2005-12-28

Completion date

2006-02-01

Last update

2026-08-16

Conditions

• Seasonal Allergic Rhinitis

Summary

The primary objective of this study is to evaluate the effect of phenylephrine 12 mg immediate-release tablet on nasal congestion compared with that of placebo in subjects with seasonal allergic rhinitis (SAR) who have been exposed to pollen in the Vienna Challenge Chamber (VCC). Pseudoephedrine 60 mg immediate-release tablet will be included in the study as an active arm.

Locations

• , , Austria

Related clinical trials

• Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study
• The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy
• Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis
• Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis
• A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis
• Acupuncture at the Sphenopalatine Ganglion in the Treatment of Moderate-to-severe Seasonal Allergic Rhinitis

View on source registry